Fatourechi V, Pajouhi M, Fransway A F
Division of Endocrinology, Metabolism, and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
Medicine (Baltimore). 1994 Jan;73(1):1-7. doi: 10.1097/00005792-199401000-00001.
Pretibial myxedema is an uncommon manifestation of Graves disease, and little information is available regarding its natural course and its relation to other manifestations of Graves disease. We reviewed 150 consecutive cases with the diagnosis of pretibial myxedema over a 20-year period in a referral center. Only 1 patient in this group did not have ophthalmopathy, whereas 88% had significant proptosis and 30% required orbital decompression surgery. Dermopathy was a late manifestation of Graves disease, and its onset usually followed the diagnosis of hyperthyroidism and ophthalmopathy. In a few patients, dermopathy preceded diagnosis of hyperthyroidism or onset of ophthalmopathy. Fourteen patients were never clinically hyperthyroid; spontaneous hypothyroidism had developed in 11 in this group. All cases involved the lower extremities, with only 1 patient having combined upper and lower extremity involvement. The most common form of thyroid dermopathy was nonpitting edema, followed by nodular and plaque forms, which occurred with equal frequency. The polypoid form occurred in 1 patient and the elephantiasic form in another; 7.3% had thyroid acropachy. Follow-up was available for 120 patients (range, 3 mo to 19 yr; mean, 3.2 yr), and complete remission was observed in only 12 patients. Topically applied corticosteroid therapy was used in 76 patients, and in this group 38% had sustained long-term partial remission, as opposed to 18% in the group receiving no corticosteroid therapy.
胫前黏液性水肿是格雷夫斯病的一种罕见表现,关于其自然病程及其与格雷夫斯病其他表现的关系,目前所知甚少。我们回顾了一家转诊中心在20年期间连续诊断为胫前黏液性水肿的150例病例。该组中只有1例患者没有眼病,而88%的患者有明显突眼,30%的患者需要进行眼眶减压手术。皮肤病变是格雷夫斯病的晚期表现,其发病通常在甲状腺功能亢进症和眼病诊断之后。在少数患者中,皮肤病变先于甲状腺功能亢进症的诊断或眼病的发作。14例患者临床上从未出现甲状腺功能亢进;该组中有11例出现了自发性甲状腺功能减退。所有病例均累及下肢,只有1例患者上下肢均受累。甲状腺皮肤病变最常见的形式是非凹陷性水肿,其次是结节状和斑块状,二者出现频率相同。息肉样形式出现在1例患者中,象皮肿样形式出现在另一例患者中;7.3%的患者有甲状腺性杵状指。120例患者获得了随访(范围为3个月至19年;平均为3.2年),仅12例患者完全缓解。76例患者使用了局部应用的皮质类固醇疗法,该组中有38%的患者长期持续部分缓解,而未接受皮质类固醇治疗的组中这一比例为18%。